| Patent application number | Description | Published |
|---|
| 20120178411 | Method and System for Implementing Emergency Location - The present invention provides a method and system for implementing emergency location. The method comprises: a User Equipment (UE) initiating an emergency call, and initiating a SUPL position procedure to a security user plane location platform (SLP); and the SLP obtaining location information of the UE through the SUPL position procedure, and providing the location information of the UE to a location request function (LRF). Using the method, the SUPL position procedure is initiated by the UE when the emergency call is initiated and the SLP is not required to support the Session Initiation Protocol (SIP), thereby simplifying design of the SLP. Furthermore, it is clear to the UE that the UE is a qualified SET, so the location request initiated by the UE can certainly be responded correctly, thereby ensuring successful implementation of the emergency call process. | 07-12-2012 |
| 20120185576 | Method and Apparatus for Acquiring Machine Type Communication Device Group Identification - The present invention discloses a method and an apparatus for acquiring machine type communication device group identification. This method comprises: acquiring the MTC device group identification from a user database by a mobility management network element after the user database subscribes to the MTC device group identification. With the present invention, the problem for transmitting the MTC device group identification in the network in related art is solved. | 07-19-2012 |
| 20120220326 | METHOD AND SYSTEM FOR ACQUIRING INFORMATION OF MACHINE TYPE COMMUNICATION USER EQUIPMENT - A method and a system for acquiring information of Machine Type Communication (MTC) user equipment (UE) are provided. The method comprises the steps of: an MTC GateWay (MTC GW) acquiring the information of the MTC UE which currently requests to attach to a network or has attached to a network from a mobility management network element; the MTC GW sending the information of the MTC UE acquired from the mobility management network element to an MTC Server. The method and the system can control the MTC UE in real time and intelligently. | 08-30-2012 |
| 20120269117 | METHOD AND SYSTEM FOR IMPLEMENTING DOMAIN SELECTION DURING THE TERMINATED CALL - The present invention discloses a method and a system for implementing domain selection during a terminated call, wherein, the method comprises: an application server (AS) sending, according to a received call request message, a query request message to a home subscriber server (HSS); the HSS querying, according to the query request message, a packet switching (PS) domain mobility management network element to obtain information of a called terminal and/or a network accessed by the called terminal in the call request message; the HSS feeding back the obtained information of the called terminal and/or the network accessed by the called terminal to the AS; and the AS selecting a domain to which a call message is to be routed according to the information of the called terminal and/or the network accessed by the called terminal. The present invention can greatly reduce the number of the signalings between the PS domain mobility management element and the HSS, avoids various limitations of the signaling loads generated by the HSS on network deployment, is convenient for the network deployment, and ensures the implementation of services. | 10-25-2012 |
| 20120287854 | METHOD AND APPARATUS FOR IMPLEMENTING ACCESS TO MACHINE TO MACHINE (M2M) CORE NTEWORK - The present invention discloses a method and an apparatus for implementing an access to a Machine to Machine (M2M) core network. In the method, a network element receives an access request message carrying equipment identity indication information, wherein the access request message is initiated by terminal equipment; the network element determines that the terminal equipment is M2M equipment according to the equipment identity indication information; and the network element selects a corresponding M2M core network for the terminal equipment to implement the access of the terminal equipment. According to the technical solution provided by the present invention, the existing network can meet the M2M service requirement while providing services for existing Human to Human (H2H) equipment, without any need of enhancement and mass expansion. | 11-15-2012 |
| 20130039277 | MACHINE TYPE COMMUNICATION EVENT REPORTING METHOD, DEVICE AND SYSTEM - Disclosed in the present invention are a Machine Type Communication event reporting method, device and system. The method includes: a mobility management network element acquires identifier information of an MTC server corresponding to an MTC device from a user subscription server; the mobility management network element sends the identifier information to an MTC event reporting entity; and the MTC event reporting entity reports an MTC event of the MTC device to the MTC server corresponding to the identifier information. By way of the present invention, the MTC event report can be sent to a correct MTC server, so that the MTC server can effectively monitor the MTC device. | 02-14-2013 |
| 20130044596 | Method and System for Controlling Access of Machine Type Communications Devices - A method for controlling access of machine type communications device is provided by the present invention. The method includes: configuring an access priority to a machine type communications device; a network side configuring a corresponding access control parameter for an access priority needing an access control according to the current network load information, and sending the access priority needing the access control and the access control parameter to the machine type communications device; and according to an access priority of the machine type communications device and the received the access priority needing the access control and the access control parameter, the machine type communications device judging whether an access request can be initiated. A system for controlling access of the machine type communications device is also provided by the present invention. | 02-21-2013 |
| Patent application number | Description | Published |
|---|
| 20100189830 | Sweet Gum Fruit Extract as a Therapeutic Agent - Sweet gum ( | 07-29-2010 |
| 20100247434 | Anti-Angiogenic Extracts from Pomegranate - An extract of Chinese blackberry ( | 09-30-2010 |
| 20110033525 | Diterpene Glycosides as Natural Solubilizers - Several diterpene glycosides (e.g., rubusoside, rebaudioside, steviol monoside and stevioside) were discovered to enhance the solubility of a number of pharmaceutically and medicinally important compounds, including but not limited to, paclitaxel, camptothecin, curcumin, tanshinone HA, capsaicin, cyclosporine, erythromycin, nystatin, itraconazole, and celecoxib. The use of the diterpene glycoside rubusoside increased solubility in all tested compounds. The diterpene glycosides are a naturally occurring class of water solubility-enhancing compounds that are non-toxic and that will be useful as new complexing agents or excipients in the pharmaceutical, agricultural (e.g., solubilizing pesticides), cosmetic and food industries. Aqueous solutions by using rubusoside to increase the solubility of otherwise insoluble drugs will have several new routes of administration. In addition, aqueous solutions of therapeutic compounds with rubusoside were shown to retain the known pharmacological activity of the compounds. | 02-10-2011 |
| 20110039796 | Natural Composition for Anti-Angiogenesis and Anti-Obesity - The combination of gallic acid, ellagic acid, and rubusoside was shown to inhibit angiogenesis by inhibition of pro-angiogenic factors. These three compounds were shown to be absorbed from the intestine making the compounds orally bioavailable. The ratio of the three compounds in the composition was a weight ratio of approximately 1:1.7:17.0 of gallic acid, ellagic acid, and rubusoside, respectively, resulting in a composition with 5% w/w gallic acid, 9% w/w ellagic acid, and 86% w/w rubusoside. This combination was also shown to reduce weight gain, fat accumulation, and serum cholesterol in mammals fed a high fat diet. It also reduced serum triglycerides and tended to reduce blood glucose in mammals on both normal and high fat diets. This three-compound composition (“GER”) can be used to treat diseases associated with angiogenesis and to decrease effects of a high fat diet. | 02-17-2011 |
| 20110165096 | Ficus Extracts Having Angiogenesis Ihibiting Activity And Methods Of Isolating And using The Same - The present invention is directed to methods for extracting and isolating extracts having angiogenesis inhibiting activity from a latex-containing portion of a | 07-07-2011 |
| 20120071431 | Platycodin Radix Extracts, and Their Use in Treating Disease Conditions Associated with Angiogenesis - Extracts of radix platycodin are used to inhibit angiogenesis, particularly angiogenesis that is associated with disease conditions other than obesity or cancer. | 03-22-2012 |
| 20120121696 | Terpene Glycosides and Their Combinations as Solubilizing Agents - Several terpene glycosides (e.g., mogroside V, paenoiflorin, geniposide, rubusoside, rebaudioside A, steviol mono-side and stevioside) were discovered to enhance the solubility of a number of pharmaceutically and medicinally important compounds, including but not limited to, paclitaxel, camptothecin, curcumin, tanshinone HA, capsaicin, cyclosporine, erythromycin, nystatin, itraconazole, celecoxib, clofazimine, digoxin, oleandrin, nifedipine, and amiodarone. The use of the diterpene glycoside rubusoside and monoterpene glycoside paenoiflorin increased solubility in all tested compounds. The terpene glycosides are a naturally occurring class of water solubility-enhancing compounds that are non-toxic and that will be useful as new complexing agents or excipients in the pharmaceutical, agricultural (e.g., solubilizing pesticides), cosmetic and food industries. | 05-17-2012 |
| 20120329738 | Water Soluble Drug-Solubilizer Powders and Their Uses - Enhanced methods have been discovered, using either sonication or homogenization followed by increased temperature and pressure, to solubilize compounds using diterpene glycosides and to produce a powder form of the compound-solubilizer complex than can be reconstituted in water. Without the diterpene glycoside, the compounds were insoluble or sparingly soluble in water, including some fat-insoluble vitamins. Water solutions of these compounds were made using a diterpene glycoside solubilizer, for example, rubusoside. The compound-solubilizer complex was then dehydrated to a stable powder that could then be reconstituted with water. A reconstituted drug-solubilizer complex (curcumin-rubusoside) was shown to be effective on reconstitution. In addition, the diterpene glycoside, rubusoside, was shown to be an inhibitor of permeability glycoprotein (P-gp), and will thus increase gastrointestinal absorption of certain drugs administered with rubusoside. | 12-27-2012 |
| Patent application number | Description | Published |
|---|
| 20110046419 | METHOD FOR PRODUCING ETHYLENE GLYCOL FROM POLYHYDROXY COMPOUND - A method for producing ethylene glycol, including (a) adding a polyhydroxy compound and water to a sealed high-pressure reactor, (b) removing air and introducing hydrogen, and (c) allowing the polyhydroxy compound to react in the presence of a catalyst while stiffing. The catalyst includes a first active ingredient and a second active ingredient. The first active ingredient includes a transition metal of Group 8, 9, or 10 selected from iron, cobalt, nickel, ruthenium, rhodium, palladium, iridium, and platinum, and/or a mixture thereof. The second active ingredient includes a metallic state of molybdenum and/or tungsten, or a carbide, nitride, or phosphide thereof. The method is carried out at a hydrogen pressure of 1-12 MPa, at a temperature of 120-300° C. for not less than 5 min in a one-step catalytic reaction. The efficiency, selectivity, and the yield of ethylene glycol are high. The preparation process is simple and the materials used are renewable. | 02-24-2011 |
| 20120172633 | METHODS FOR PREPARING ETHYLENE GLYCOL FROM POLYHYDROXY COMPOUNDS - This invention provides methods for producing ethylene glycol from polyhydroxy compounds such as cellulose, starch, hemicellulose, glucose, sucrose, fructose, fructan, xylose and soluble xylooligosaccharides. The methods uses polyhydroxy compounds as the reactant, a composite catalyst having active components comprising one or more transition metals of Groups 8, 9, or 10, including iron, cobalt, nickel, ruthenium, rhodium, palladium, iridium, and platinum, as well as tungsten oxide, tungsten sulfide, tungsten hydroxide, tungsten chloride, tungsten bronze oxide, tungsten acid, tungstate, metatungstate acid, metatungstate, paratungstate acid, paratungstate, peroxotungstic acid, pertungstate, heteropoly acid containing tungsten. Reacting at a temperature of 120-300° C. and a hydrogen pressure of 1-13 MPa under hydrothermal conditions to accomplish one-step catalytic conversion. It realizes efficient, highly selective, high yield preparation of ethylene glycol and propylene glycol from polyhydroxy compounds. The advantage of processes disclosed in this invention include renewable raw material and high atom economy. At the same time, compared with other technologies that converts biomass raw materials into polyols, methods disclosed herein enjoy advantages including simple reaction process, high yield of targeted products, as well as easy preparation and low cost for the catalysts. | 07-05-2012 |
| Patent application number | Description | Published |
|---|
| 20100056532 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM - Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity. | 03-04-2010 |
| 20100093734 | CYTOKINE INHIBITORS - The present invention provides low molecular weight compounds useful as cytokine inhibitors, and compositions thereof. In particular, compounds of the invention are useful as anti-inflammatory agents. There are further provided methods for the preparation of such agents and their use in preventing or treating conditions mediated by cytokines such as arthritis. | 04-15-2010 |
| 20100261725 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM - Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity. | 10-14-2010 |
| 20100273797 | ALPHA-KETOAMIDES AND DERIVATIVES THEREOF - The present invention provides low molecular weight compounds useful as cytokine inhibitors, and compositions thereof. In particular, compounds of the invention are useful as anti-inflammatory agents. There are further provided methods for the preparation of such agents and their use in preventing or treating conditions medicated by cytokines such as arthritis. | 10-28-2010 |
| 20110065724 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM - Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity. | 03-17-2011 |
| 20110136816 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM - Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity. | 06-09-2011 |
| 20110166159 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM - Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity. | 07-07-2011 |
| 20110212970 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM - Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity. | 09-01-2011 |
| 20110263612 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM - Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity. | 10-27-2011 |
| 20120071516 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM - Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity. | 03-22-2012 |
| 20120316182 | COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM - Described herein are compounds and pharmaceutical compositions containing such compounds, which modulate the activity of store-operated calcium (SOC) channels. Also described herein are methods of using such SOC channel modulators, alone and in combination with other compounds, for treating diseases or conditions that would benefit from inhibition of SOC channel activity. | 12-13-2012 |
| Patent application number | Description | Published |
|---|
| 20120272874 | Biomass Fuel Internal Circulation Mechanical Fluidized-Bed Corner Tube Intelligent Boiler - The present invention discloses a biomass fuel internal circulation mechanical fluidized-bed corner tube intelligent boiler which is highly effective in energy-conservation and emission-reduction, which comprises a primary combustion chamber, a secondary combustion chamber, a burning-out chamber, a high temperature multi-tube cyclone dust collector, a heat convection pipe bundle, the hearth of the primary combustion chamber consists of a square membrane water-cooled wall and a profiled seat with a square top and a circular bottom, at the four corners of the seat, there are mounted Venturi tube internal circulators, at the bottom of the hearth, there is mounted a mechanical fluidizing machine; the profiled cyclone separation hearth of the secondary combustion chamber consists of a square membrane water-cooled wall, a profiled seat with a square top and a circular bottom, a profiled fume-venting tube, at the bottom of the hearth, there is mounted a mechanical fluidizing machine; the burning-out chamber is connected with the inlet of the high temperature multi-tube cyclone dust collector; and the outlet of the high temperature multi-tube cyclone dust collector is connected with the heat convection pipe bundle. With the boiler of the present invention, the combustion intensity is high, the combustion is sufficient, no slag formation occurs, the thermal conversion efficiency is high, the pollution of the thermal convection is reduced and the boiler is capable of running stably for a long time, has a wide range of adjustment and is capable of intelligent self-control. | 11-01-2012 |
